The Protein Brewery has laid the groundwork to commercialize Fermotein at scale The Protein Brewery, a leader in fungi-based food ingredients, announces the successful closing of its €30 million Series…

The Protein Brewery has laid the groundwork to commercialize Fermotein at scale

The Protein Brewery, a leader in fungi-based food ingredients, announces the successful closing of its €30 million Series B round. The funding marks the next phase of The Protein Brewery’s journey: strengthening its commercial presence, advancing Fermotein – its proprietary mycoprotein – and its innovation platform to serve food manufacturers worldwide, and expanding production capacity.

The round welcomed new investors Invest-NL and the Brabant Development Agency (BOM), alongside existing investors Novo Holdings, Unovis Asset Management, and Madeli.
 
Following its Series A round four years ago, The Protein Brewery has laid the groundwork to commercialize Fermotein at scale. This new funding will be used to:

Strengthening sales and application expertise to ensure Fermotein meets the needs of food manufacturers worldwide.

Commercialize Fermetin in the United States and Europe,
accelerating business growth in key market segments.

Expand production at the Mijkenbroek facility, solidifying our readiness for large-scale commercialization.

Develop the Fermotein innovation platform, unlocking new possibilities in nutrition and product applications.

“This funding is a springboard for global expansion. With Fermotein, we are not just offering another protein – we are redefining how food is made: nutritious, sustainable, and scalable at a lower cost. The Protein Brewery is ready to lead the protein and fiber transition,” said Thijs Bosch, CEO of The Protein Brewery. “We are now entering a defining moment: all building blocks of operation are in place, and we are ready to accelerate.”

As part of this round, Thomas Grotkjær, Partner at Novo Holdings, highlighted The Protein Brewery’s readiness to scale: “The Protein Brewery has built the infrastructure, laid the groundwork, and is now positioned to bring biotech-driven food innovation to the global stage. This funding fuels its ability to drive real impact in the food industry.”